Tectonic Therapeutic
TECX
57 hedge funds and large institutions have $379M invested in Tectonic Therapeutic in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 10 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 12
38% more capital invested
Capital invested by funds: $274M → $379M (+$105M)
0.16% more ownership
Funds ownership: 5.79% → 5.95% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 59 → 57 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$8.88M |
| 2 |
BlackRock
New York
|
+$6.03M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.77M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.81M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$16.1M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$12.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$5.26M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.02M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.06M |
TECX Hedge Fund Activity: Q1 2019 in Review
57 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q1 2019, worth a combined $379M — up 38% from $274M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TECX and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 30 added.
The largest buyer was JP Morgan Chase, adding an estimated $8.88M. The largest seller was Cormorant Asset Management, cutting an estimated $16.1M.
- 57 institutional investors held Tectonic Therapeutic (TECX) as of Q1 2019, down from 59 in Q4 2018.
- Funds reported $379M of Tectonic Therapeutic stock for Q1 2019, up 38% quarter-over-quarter.
- 8 funds opened new Tectonic Therapeutic positions in Q1 2019 and 10 closed out, a net change of -2 holders.
- The largest Tectonic Therapeutic buyer in Q1 2019 was JP Morgan Chase, an estimated $8.88M added.
- The largest Tectonic Therapeutic seller in Q1 2019 was Cormorant Asset Management, an estimated $16.1M sold.
Based on aggregated 13F filings for Q1 2019.